Compare PMCB & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMCB | GP |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | Canada |
| Employees | 2 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.3M |
| IPO Year | 2001 | 2013 |
| Metric | PMCB | GP |
|---|---|---|
| Price | $0.37 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 99.3K | ★ 1.4M |
| Earning Date | 12-17-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $308.21 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.19 |
| 52 Week High | $1.51 | $2.19 |
| Indicator | PMCB | GP |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 39.40 |
| Support Level | $0.32 | $0.51 |
| Resistance Level | $0.40 | $1.17 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 58.20 | 8.80 |
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
GreenPower Motor Co Inc is a manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector. The Company operates in one reportable operating segment, being the manufacture and distribution of all electric commercial vehicles and transit, school and charter buses. Geographically the company has presence in Canada, and United States of America. The company generates majority of revenue from United States of America.